ETC-1002,also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies.ETC-1002 is an activator of hepatic AMP-activated protein kinase (AMPK). It has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
For research use only. We do not sell to patients.
| Name | ETC-1002 |
|---|---|
| Iupac Chemical Name | ETC-1002 |
| Synonyms | Bempedoic acid, ESP-55016 |
| Molecular Formula | C19H36O5 |
| Molecular Weight | 344.49 |
| Smile | CC(C)(CCCCCC(CCCCCC(C)(C)C(=O)O)O)C(=O)O |
| InChiKey | HYHMLYSLQUKXKP-UHFFFAOYSA-N |
| InChi | InChI=1S/C19H36O5/c1-18(2,16(21)22)13-9-5-7-11-15(20)12-8-6-10-14-19(3,4)17(23)24/h15,20H,5-14H2,1-4H3,(H,21,22)(H,23,24) |
| CAS Number | 738606-46-7 |
| MDL | MFCD18800820 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |